SeLux Diagnostics, Inc.
Biotechnology company · Charlestown, Massachusetts, United States
SeLux Diagnostics, Inc. is a biotechnology company headquartered in Charlestown, Massachusetts, United States. Its earliest recorded incorporation is in 2014. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $5.1 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $40 million sold in a notice filed in 2024.
SeLux Diagnostics at a glance
What does SeLux Diagnostics do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $5.1 million in total (2016 to 2021). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development.
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $40 million sold (2024).
Frequently asked questions about SeLux Diagnostics
Where is SeLux Diagnostics headquartered?
SeLux Diagnostics, Inc. is headquartered in Charlestown, Massachusetts, United States.
What does SeLux Diagnostics do?
SeLux Diagnostics, Inc. is a biotechnology company.
When was SeLux Diagnostics founded?
The earliest incorporation on record for SeLux Diagnostics, Inc. is in 2014, according to public company registers.
Similar companies
- Solid Biosciences Inc.Charlestown, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences